HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

James A Bonner Selected Research

Phosphotransferases (Kinase)

3/2022EGFR Mutations in Head and Neck Squamous Cell Carcinoma.
6/2019Myristoylated alanine-rich C-kinase substrate effector domain phosphorylation regulates the growth and radiation sensitization of glioblastoma.
3/2015Targeting the effector domain of the myristoylated alanine rich C-kinase substrate enhances lung cancer radiation sensitivity.
6/2014Kinomic exploration of temozolomide and radiation resistance in Glioblastoma multiforme xenolines.
1/2014Kinomic profiling of electromagnetic navigational bronchoscopy specimens: a new approach for personalized medicine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


James A Bonner Research Topics

Disease

48Neoplasms (Cancer)
03/2022 - 11/2002
28Head and Neck Neoplasms (Head and Neck Cancer)
01/2022 - 07/2002
15Squamous Cell Carcinoma of Head and Neck
03/2022 - 07/2002
9Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2020 - 09/2009
9Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2014 - 10/2002
6Carcinoma (Carcinomatosis)
10/2019 - 07/2002
5Lung Neoplasms (Lung Cancer)
01/2018 - 11/2002
5Small Cell Lung Carcinoma (Small Cell Lung Cancer)
08/2012 - 07/2004
4Deglutition Disorders (Dysphagia)
01/2021 - 02/2009
3Glioblastoma (Glioblastoma Multiforme)
06/2019 - 06/2012
3Pancreatic Neoplasms (Pancreatic Cancer)
01/2009 - 11/2002
2Adenocarcinoma
01/2018 - 03/2015
2Squamous Cell Neoplasms (Squamous Cell Cancer)
01/2016 - 11/2011
2Mucositis
01/2016 - 09/2014
2Exanthema (Rash)
09/2014 - 01/2010
2Neoplasm Metastasis (Metastasis)
03/2013 - 03/2011
2Breast Neoplasms (Breast Cancer)
09/2012 - 01/2010
2Disease Progression
01/2011 - 02/2006
2Pathologic Constriction (Stenosis)
02/2010 - 02/2009
1Pain (Aches)
01/2021
1Body Weight (Weight, Body)
01/2020
1Colorectal Neoplasms (Colorectal Cancer)
10/2019
1Triple Negative Breast Neoplasms
09/2019
1Anorexia
09/2014
1Hypokalemia
09/2014
1Fatigue
09/2014
1Nasopharyngeal Neoplasms (Cancer of the Nasopharynx)
08/2013
1Laryngeal Neoplasms (Laryngeal Cancer)
08/2013
1Ovarian Neoplasms (Ovarian Cancer)
09/2012

Drug/Important Bio-Agent (IBA)

20Cetuximab (Erbitux)FDA Link
01/2020 - 07/2002
12ErbB Receptors (EGF Receptor)IBA
01/2020 - 07/2002
9Cisplatin (Platino)FDA LinkGeneric
01/2020 - 07/2002
6Pharmaceutical PreparationsIBA
03/2022 - 03/2003
6Monoclonal AntibodiesIBA
03/2022 - 03/2003
5Phosphotransferases (Kinase)IBA
03/2022 - 01/2014
4Biomarkers (Surrogate Marker)IBA
09/2019 - 06/2011
4Proteins (Proteins, Gene)FDA Link
06/2019 - 01/2011
4Poly(ADP-ribose) Polymerase InhibitorsIBA
09/2015 - 01/2011
4veliparibIBA
09/2015 - 01/2011
3Epidermal Growth Factor (EGF)IBA
01/2020 - 11/2002
3DNA (Deoxyribonucleic Acid)IBA
01/2020 - 06/2012
3Myristoylated Alanine-Rich C Kinase SubstrateIBA
06/2019 - 06/2012
3GemcitabineFDA Link
01/2018 - 11/2002
3Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
09/2015 - 01/2011
3Biological ProductsIBA
01/2014 - 11/2007
3Paclitaxel (Taxol)FDA LinkGeneric
01/2010 - 03/2003
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
03/2022 - 01/2020
2Immune Checkpoint InhibitorsIBA
11/2021 - 09/2019
2olaparibIBA
01/2020 - 09/2012
2tyrosine receptor (receptor, tyrosine)IBA
06/2019 - 03/2015
2PlatinumIBA
12/2017 - 07/2008
2Peptides (Polypeptides)IBA
03/2015 - 03/2003
2P 11 (P-11)IBA
08/2012 - 03/2011
2Small Interfering RNA (siRNA)IBA
06/2011 - 09/2009
2BariumIBA
02/2010 - 02/2009
2Ethylene Glycol (Monoethylene Glycol)IBA
01/2010 - 11/2007
2Taxoids (Taxanes)IBA
01/2010 - 03/2003
2Tyrosine Kinase InhibitorsIBA
09/2007 - 01/2006
2Erlotinib Hydrochloride (CP 358,774)FDA Link
09/2007 - 01/2006
2Etoposide (VP 16)FDA LinkGeneric
07/2007 - 06/2005
1Oxycodone (Oxycontin)FDA LinkGeneric
01/2021
1LipidsIBA
01/2021
1LigandsIBA
01/2020
18- dibenzothiophen- 4- yl- 2- morpholin- 4- yl- chromen- 4- oneIBA
01/2020
1130-nm albumin-bound paclitaxelIBA
09/2019
1pembrolizumabIBA
09/2019
1AlbuminsIBA
09/2019
1Phospholipids (Phosphatides)FDA LinkGeneric
06/2019
1TensinsIBA
06/2019
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
06/2019
1SialyltransferasesIBA
01/2018
1antineoplaston A10 (A 10)IBA
09/2015
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
03/2015
1Endothelial Growth FactorsIBA
08/2014
1pazopanibFDA Link
08/2014
1Temozolomide (Temodar)FDA LinkGeneric
06/2014
1O-(6)-methylguanineIBA
06/2012
1MethyltransferasesIBA
06/2012
1tigatuzumabIBA
10/2011
1DNA Repair EnzymesIBA
06/2011

Therapy/Procedure

45Radiotherapy
01/2022 - 07/2002
16Drug Therapy (Chemotherapy)
01/2016 - 07/2002
13Therapeutics
11/2021 - 05/2003
6Gastrostomy
01/2021 - 02/2009
4Re-Irradiation
01/2019 - 01/2018
4Enteral Nutrition (Feeding, Tube)
01/2018 - 03/2012
3Combined Modality Therapy
01/2021 - 09/2003
3Cranial Irradiation
01/2011 - 07/2007
3Aftercare (After-Treatment)
01/2011 - 06/2007
2Immunotherapy
11/2021 - 09/2019
2Precision Medicine
09/2019 - 01/2014
2Tracheostomy
01/2018 - 01/2018
2Chemoradiotherapy
12/2017 - 11/2011
1Microspheres (Microsphere)
01/2021
1Pain Management
01/2021
1Analgesia
01/2021
1Particle Accelerators
11/2013
1Nutritional Support (Artificial Feeding)
03/2012
1Tracheotomy
10/2011
1Neoadjuvant Therapy
03/2011